1.61 USD
↘ 0.11 (6.83%)AT CLOSE (AS OF 04:15 PM EDT)
BioNexus Gene Lab Corp Common stock
BGLCNASDAQ • USD
Market: CLOSED
BioNexus Gene Lab Corp Common stock (BGLC) is currently trading at $1.61. Our models show a "Sell" technical signal alongside a "Neutral" fundamental rating. This is driven by a robust Altman Z-Score, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics suggest BGLC is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Sep 14, 2026.
Open?$1.45
High?$1.50
Low?$1.45
Prev. Close?$1.61
Volume?1.6K
Avg. Volume?14.8K
VWAP?$1.52
Rel. Volume?0.11x
Bid / Ask
Bid?$1.27 × 100
Ask?$1.79 × 100
Spread?$0.52
Midpoint?$1.53
Valuation & Ratios
Market Cap?4.7M
Shares Out?2.9M
Float?1.7M
Float %?71.0%
P/E Ratio?N/A
P/B Ratio?0.61
EPS?-$0.88
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.
Employees
1
Market Cap
4.7M
Industry
SERVICES-MEDICAL LABORATORIES
Website
Listed
2020-03-11
Address
UNIT A-28-7, TOWER A, MENARA UOA BANGSAR
KUALA LUMPUR, 59000
Phone: 1-307-241-6898
KUALA LUMPUR, 59000
Phone: 1-307-241-6898
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?82
Momentum?23
Short Sent.?70
Piotroski F-Score?3/9Weak
Altman Z-Score?3.42Safe
Confidence?54%Low
Short InterestLow
Short % of Float?0.45%Low
Short Interest?7.5K
Days to Cover?1.0
Free Float1.7M
Avg Daily Volume13.2K
Settlement Date2026-08-31
Financial Health
Current Ratio?6.08Strong
Quick Ratio?5.28Strong
Cash Ratio?1.52Strong
Debt/Equity?0.01Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.61CHEAP▾
Peers100
S&P97
P/S?1.51CHEAP▾
Peers100
S&P78
P/FCF?N/A▾
EV/EBITDA?-1.3CHEAP▾
S&P97
EV/Sales?1.13CHEAP▾
Peers100
S&P90
Returns & Efficiency
ROE?-33.1%WEAK▾
S&P6
ROA?-29.5%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-853600
Enterprise Value?$3.5M
Fundamentals ratios updated end of day